Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
Not yet recruiting · NCT07521670 · Registry updated 2026-07-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) | Disease Attributes, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Thyroid Cancer, Papillary, adenocarcinoma, adenoid cystic carcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, papillary adenocarcinoma, thyroid gland disorder, thyroid tumor | Not yet recruiting | Phase 2 | 2026-07-15 | NCT07521670 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| National Cancer Center, Japan | 16 |
| National Cancer Centre, Singapore | 44 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Cancer Center Hospital | Tokyo | Japan | 20 |
| National Cancer Center Korea | Gyeonggi-do | South Korea | 1 |
| National Cancer Centre Singapore | Singapore | Singapore | 8 |
| Sarawak General Hospital | Kuching | Malaysia | 3 |
| Seoul National University Hospital | Seoul | South Korea | 183 |
| Tan Tock Seng Hospital | Singapore | Singapore | 22 |
| University of Malaya Medical Center | Kuala Lumpur | Malaysia | 2 |